Exploring the antineoplastic potential of α-mangostin in breast cancer
Open Access
- 3 July 2025
- journal article
- review article
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 15 (1) , 1-30
Abstract
Among women, breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related mortality globally. Despite improvements in early detection and diagnosis, some risk factors have been on the rise, including the decline in birth rate, the use of oral contraceptives, and the escalation in alcohol consumption and obesity. Thus, there is an imperative urgent need to expand accessible prevention and treatment options for breast cancer. Regarding these tumors, several natural compounds have shown efficacy in slowing or preventing their progression, offering a promising therapeutic alternative. Among these, α-mangostin, a xanthone derived from mangosteen, has demonstrated promising antitumor effects against different malignancies, particularly breast cancer. The mechanisms involved in α-mangostin´s therapeutic effects include downregulation of oncogenic ion channels, modulation of cell cycle progression, suppression of oncogene expression, and interference with steroid and growth factor receptors signaling. This review thoroughly explores these mechanisms, as well as updates information on α-mangostin chemical structure and its potential as a coadjuvant to conventional breast cancer therapies. Furthermore, we provide scientifically supported insights for the development of clinically applicable α-mangostin-based treatments, highlighting the robust body of evidence supporting its cancer-fighting properties, despite the absence of clinical studies to date. Graphical AbstractKeywords
This publication has 164 references indexed in Scilit:
- The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advancesCell Biochemistry and Function, 2024
- Xanthones and Cancer: from Natural Sources to Mechanisms of ActionChemistry & Biodiversity, 2019
- Daily consumption of a mangosteen‐based drink improves in vivo antioxidant and anti‐inflammatory biomarkers in healthy adults: a randomized, double‐blind, placebo‐controlled clinical trialFood Science & Nutrition, 2015
- Functional beverage of Garcinia mangostana (mangosteen) enhances plasma antioxidant capacity in healthy adultsFood Science & Nutrition, 2014
- Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in miceMolecular Nutrition & Food Research, 2014
- Efficacy and tolerability of a novel herbal formulation for weight managementObesity, 2013
- Anti‐tumorigenicity of dietary α‐mangostin in an HT‐29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolitesMolecular Nutrition & Food Research, 2012
- Bioaccessibility, biotransformation, and transport of α‐mangostin from Garcinia mangostana (Mangosteen) using simulated digestion and Caco‐2 human intestinal cellsMolecular Nutrition & Food Research, 2009
- Cardioprotective effect of α‐mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol‐induced myocardial infarction in ratsJournal of Biochemical and Molecular Toxicology, 2007
- HPLC analysis of selected xanthones in mangosteen fruitJournal of Separation Science, 2007